PEPTIDE AND PROTEIN BIOANALYSIS

Importance of the topic

Desmopressin is a synthetic analogue of vasopressin used to treat conditions such as diabetes insipidus and nocturnal enuresis. Accurate measurement of desmopressin in plasma at low pg/mL levels is critical for pharmacokinetic and bioequivalence studies, especially in pediatric and renally impaired populations where dosing precision is essential.

Objectives and study overview

This study aimed to develop and validate a high-sensitivity, high-throughput LC-MS/MS assay for desmopressin in rat plasma. The method was optimized for selectivity, robustness, and sensitivity, targeting a lower limit of quantification (LLOQ) of 1 pg/mL. Key performance metrics included linearity, precision, accuracy, and throughput.

Methodology and instrumentation

• Sample preparation: Rat plasma (500 μL) was acidified, loaded onto an Oasis WCX SPE cartridge, washed under basic conditions, eluted, dried, and reconstituted in mobile phase.
• Chromatography: ACQUITY UPLC HSS T3 column (2.1 × 100 mm, 1.8 μm) with a 5 min gradient (10–90% organic) at 0.25 mL/min and 50 °C.
• Mass spectrometry: Xevo TQ-S tandem quadrupole MS in positive ESI mode; MRM transitions 535.4 → 328.2 for desmopressin and 542.7 → 328.2 for vasopressin (internal standard).

Results and discussion

The assay was linear over 1–200 pg/mL with r² > 0.99. The LLOQ of 1 pg/mL showed clear, symmetrical peaks and S/N > 10. Intra- and inter-day precision and accuracy at QC levels (1, 10, 100 pg/mL) were within 3–9% CV and 96–102% recovery. Matrix effects were <8%, and carryover was negligible. Total cycle time was 6 min, supporting high throughput.

Benefits and practical applications

• The method achieves sub-pg/mL sensitivity, enabling detailed PK profiling of desmopressin.
• SPE cleanup combined with UPLC and Xevo TQ-S ensures high selectivity and low matrix effects.
• Fast run times and robust SPE make it suitable for large preclinical and clinical studies.
• Minimal sample preparation and instrument time reduce costs and improve throughput.

Future trends and potential applications

Integrating microflow or nanoscale UPLC sources (ionKey/MS) could further reduce sample and solvent use while improving sensitivity. Expanding to other peptide therapeutics and biomarker analytes will broaden translational research capabilities. Automation of SPE and sample preparation can enable even higher throughput.

Conclusion

A highly sensitive, robust, and rapid UPLC-MS/MS method was developed and validated for desmopressin quantification in rat plasma with an LLOQ of 1 pg/mL. The combination of mixed-mode SPE, ACQUITY UPLC HSS T3 separation, and Xevo TQ-S detection provides a powerful platform for peptide bioanalysis in preclinical and clinical settings.

Reference

1. Rajesh PMN, Vaidyanathan G. “High Sensitivity UPLC/MS/MS Method for Desmopressin in Rat Plasma.” Waters Application Note, 2013.